跳至主要内容
临床试验/NCT04188197
NCT04188197已完成不适用

Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes

Rose Research Center, LLC3 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年8月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
3
主要终点
Effects of Devaluation on Switching From Cigarettes to the JUUL E-cigarette

研究概览

简要总结

This study will evaluate a reward devaluation strategy in which smokers use the JUUL e-cigarette immediately before any combustible cigarettes (CCs) are smoked. This procedure is predicted to accomplish three goals: 1) the rewarding effects of CC will be disrupted because subjects will already have attained fairly high peak nicotine concentrations immediately before smoking the cigarette. This reduces the rewarding effect of smoking, in part from receptor desensitization that occurs following nicotine exposure, which reduces the response to a subsequent dose of nicotine, and in part from satiating the drive to smoke; 2) the use of the JUUL will become associated with the same cues that elicit smoking, thereby promoting the substitution of JUUL use for CC use; and 3) ad libitum nicotine intake from the JUUL and its rewarding effects will be maximized because, unlike CC, they will be experienced after a period of nicotine deprivation. Thus, despite a lower per-puff nicotine dose relative to CC, the pharmacologic impact and reinforcing effect will be maximized. The study will evaluate two flavors (Mint and Virginia Tobacco), randomly assigned, to determine if flavor assignment (similar to the subjects' usual brand of CC or different than the subjects usual brand CC) has an effect on the success of this reconditioning procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has signed the ICF and is able to understand the information provided in the ICF.
  • Is 21 to 65 years of age (inclusive) at screening.
  • Smokes ≥ 10 commercially available CCs per day (no brand restrictions), for the last 12 months.
  • Expired air CO reading of at least 10 ppm as assessed at the screening session.
  • Interested in switching to an electronic cigarette.
  • Willing and able to comply with the requirements of the study.
  • Owns a smartphone with text message and data capabilities compatible with necessary surveys.

排除标准

  • Is unhealthy or cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason) as judged by the Investigator or designated medical staff based on all available assessments from the screening period (e.g., safety laboratory, vital signs, physical examination, ECG, concomitant medications and medical history).
  • PHQ-9 score greater than 9, or a score greater than 0 on item #9 ("Thoughts that you would be better off dead, or of hurting yourself in some way") at screening.
  • Planned use of an FDA-approved smoking cessation product during the study.
  • High Blood Pressure (systolic >150 mm Hg, diastolic >95 mm Hg) at screening.
  • Body mass index (BMI) less than 15.0 kg/m2 or greater than 40.0 kg/m
  • Coronary heart disease, structural cardiac disease (including, but not limited to valvular heart disease or cardiac murmurs), cardiac dysrhythmias, syncope, cardiac chest pain, or history of heart attack or heart failure.
  • Has received psychotherapy or behavioral treatments within 30 days of screening, or during the study.
  • Taking antidepressants or psychoactive medications (e.g. antipsychotics, benzodiazepines, hypnotics).
  • Use of any of these products in the past 30 days:
  • Illegal drugs (or if the urine drug screen is positive for cocaine, THC, amphetamines, methamphetamines, or opiates);
  • Experimental (investigational) drugs that are unknown to the subject;
  • Chronic opiate use.
  • Use of smokeless tobacco (chewing tobacco, snuff), cigars (except for "Black & Mild" cigars or Cigarillos), pipes, hookah, e-cigarettes, nicotine replacement therapy or other smoking cessation treatments within 14 days of screening.
  • Pregnant or nursing (by self-report) or positive pregnancy test.

结局指标

主要结局

Effects of Devaluation on Switching From Cigarettes to the JUUL E-cigarette

时间窗: During Weeks 9-12

Biochemically verified smoking abstinence during weeks 9-12, i.e., self-report of no smoking confirmed by an expired air CO reading of \<5 ppm.

次要结局

  • Changes in Cigarette Reward With Subsequent Switching Behavior(Week 1)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Jed Rose

President and CEO

Rose Research Center, LLC

研究点 (3)

Loading locations...

相似试验

已完成
2 期
Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserineSmoking CessationHarm Reduction
NCT05994703Rose Research Center, LLC25
已完成
不适用
Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment FailuresSmoking, Cigarette
NCT03502200Ohio State University Comprehensive Cancer Center350
撤回
不适用
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungHead and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaStage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
NCT05412875Ohio State University Comprehensive Cancer Center
已完成
不适用
E-cigarettes to Promote Smoking Reduction Among Individuals With SchizophreniaTobacco Smoking
NCT02918630The University of Texas Health Science Center, Houston7
进行中(未招募)
早期 1 期
Electronic Cigarette-derived Oxidants and Cardiopulmonary EffectsChronic Obstructive Pulmonary Disease
NCT05239793Milton S. Hershey Medical Center30
Assisting Smokers to Switch to a JUUL E-Cigarette by... | 临床试验